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Abstract
A case is described in which a man with chronic pain
syndrome (CPS) presented to a city General hospital in
suicidal crisis after referral from a provincial psychiatric unit,
having taken an overdose of a variety of medications,
precipitated by the absence of his opioid (Oxycontin)
analgesia which he had been abusing intra-nasally. This is
to our knowledge the first reported case in Europe of drug
diversion from oral to intranasal use of Oxycontin, a
controlled-release preparation of the synthetic opiate,
oxycodone hydrochloride. There is also a dearth of
reference to the abuse potential of this agent in the
European literature. As sufferers from chronic pain
syndrome increase in number, and opiate prescription rates
worldwide are maintained, this case highlights the potential
of opiate abuse or dependence and drug diversion
emerging as a significant medical problem in CPS patients
in Europe.
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Introduction
Over the past three decades, there has been a significant
increase in opiate abuse in Ireland.1 A newer oral opiate deriv-
ative analgesic, oxycodone, has been marketed in Ireland in
recent years for chronic pain syndrome (CPS). We describe
the first recorded case in the European literature of intra-
nasal oxycodone abuse, prescribed orally for a patient with
CPS.
Case history
Overview
A 39 year old Irish national was admitted to a Dublin city
hospital Pain Management Programme (PMP) from a provin-
cial psychiatric unit with symptoms of depression and suicidal
ideation secondary to his CPS and his admitted dependence
upon his prescribed oxycodone, which he was taking intra-
nasally. He was to be commenced on methadone, having
taken two recent overdoses in “serious” attempts to kill
himself.
Almost a year before, the PMP had prescribed Oxycontin,
titrated to 60mg b.i.d for CPS. He informed the staff at
presentation to the psychiatric unit that he was abusing his
Oxycontin by crushing it into powder and snorting it intra-
nasally. His one month supply was consequently lasting only
two weeks. He ascribed his suicidality and hopelessness to
his CPS, present since 1987 (see Table 1).
Since 1994 he has attended the PMP. In February 2002,
Oxycontin 60mg b.i.d and Oxynorm (immediate-release
formula) 10mg b.i.d prm were prescribed. The patient, having
previously snorted both cocaine and heroin intra-nasally was
aware of the abuse potential of the drug when converted to a
powder form. Apparently he had discovered on the Internet
that Oxycontin could be taken intra-nasally once the coating
was disabled by crushing. He began to use the oxycodone
accordingly.
Tolerance reduced his prescription to lasting two weeks,
although withdrawal symptoms were minimal, possibly due to
his other psychotropic medication. 
Past psychiatric history
In 1994, the patient was referred to group therapy in a
psychiatric hospital in Dublin after his mother died. The Coro-
ner’s inquest recorded a verdict of death by misadventure,
from a combination of disulfiram and alcohol.
The group therapy “eased” a lot of his “residual anger”
toward his mother for “drinking herself to death”. He was
granted permanent disability status after another accident in
1996. At that time, he commenced paroxetine from his GP
and bromazepam 1.5mg t.i.d for agitation. He continued on
this medication for eighteen months and denies misusing it.
He drank heavily, falling asleep while socialising on occasion.
In 2001 he was commenced on venlafaxine XL 75mg once
daily by a private psychiatrist who then referred him back to
his catchment area service, and the antidepressant dose was
increased incrementally to 225mg once daily by 2002. Alpra-
zolam 0.5mg t.i.d was added for anxiety/agitation and
olanzapine for insomnia.
Psychiatric assessment at most recent hospital-
isation
Early childhood and education
The patient was the younger son of a sibship of two. He
described a “very happy” childhood, but conceded that his
mother was severely alcohol-dependent. He enjoyed school
at primary level, and was popular and good at games. 
When he moved to secondary school, he never really
settled down, as he felt like “a loner”. His academic perfor-
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mance declined. At 16 years old he began experimenting
with Cannabis. He “dabbled” in illicit drug use for several
years.
Adulthood
At 18 years of age he suffered a fractured femur and tibia
playing football, which left him incapacitated for most of his
Leaving Certificate year. He barely passed his examination
and decided to repeat same. The following year he again
fractured his femur. Two weeks later he repeated his Leaving
Certificate in hospital. He slept through most of the exami-
nations due to the sedative analgesia and failed his
examination.
Employment history
His leg healed. He worked in the construction industry,
subsequently qualifying in Construction Studies. He moved
to London to live with his father who was employed in the
construction industry there. A year later he moved home
again.
Medication
Upon admission under the care of the PMP, his medication
was venlafaxine XL 225mg once daily, amitryptiline 50mg
nocte, alprazolam 0.5mg t.i.d and olanzapine 10mg nocte.
His oxycodone prescription had been discontinued in the
psychiatric unit. The pain management team did not carry out
urine toxicology, although the patient admitted intermittent
cannabis use.
Pre-morbid personality
He described himself as “lively and outgoing” and felt that
he was reasonably affable toward others. He admitted to
being somewhat impulsive in nature, leading to a chequered
employment record and being fired from his last job as a
materials manager.
Mental state examination 
Upon admission to the PMP service, mental state exami-
nation revealed a well-dressed and groomed man who
engaged fully with the interviewer. He appeared relaxed
throughout the interview, but expressed low mood, strong
suicidal ideation and high degree of hopelessness in a
detached and matter of fact manner. He felt his relationship
of nine years, from which he had a five year old son, was
“doomed”, resulting from his disability and incapacity to
contribute to the domestic income. He had become emotion-
ally distant from his partner. There was no contact between
them during his hospital stay. He was not psychotic or
thought-disordered and was of high-average intelligence. He
acknowledged the intra-nasal oxycodone abuse and agreed
to a methadone substitution programme.
Physical examination was essentially normal. He described
pain on all movements, none of which were restricted in
range to any significant degree.
Treatment
Under the supervision of the psychiatric team his
psychotropic medication was rationalised. The PMP titrated
his methadone against his pain severity, using it additionally
as a substitute for his oxycodone dependence.
Discharge plan
At his self-discharge after three weeks hospitalisation he
was no longer expressing suicidal ideation. His prescription
was; methadone 15mg t.i.d.; celecoxib 200mg b.i.d; zolpidem
10mg nocte and venlafaxine XL 225mg daily. He was
referred back to the local psychiatric service for further
substance rehabilitation and follow-up.
Discussion
To our knowledge, this is the first reported case in the Euro-
pean literature of drug diversion of Oxycontin from oral to
intranasal route during the treatment of a chronic pain
syndrome, a well recognised phenomenon in the US.9
However, it should be noted that oxycodone is administered
as an intra-nasal spray in circumstances where the oral route
is compromised or more rapid onset of analgesic action is
required.11 The use of crushed oxycontin has been reported
to be associated with total necrosis of the nasal septum,
sinuses and soft palate. It is likely that it will feature in the
future as a street drug of abuse.12 Known in the US as ‘Hill-
billy Heroin’ or ‘poor man’s heroin’, its abuse potential was
first realised in the Appalachian region and West Virginia in
particular.9 The drug has a street value in the US ranging from
50c to $1 per milligram. The amount of crime related specif-
ically to oxycodone is now a matter of statistic. In some
counties of the Appalachian region, it accounts for up to 80%
of indictable crime. 
Some pharmacies in the US have refused to stock the drug
for security reasons. Chronic pain is a recognised risk factor
Age Injury Cause Treatment Sequelae- physical/psychological
18 # femur & tibia Playing football POP & NSAIDs. Needed crutches for mobility. Cannabis use began. 
19 # femur Friend fell on him POP & NSAIDs. Increased use of Cannabis. Commenced weekly MDMA, 
while both intoxicated cocaine & heroin intranasally.
24 facial pain Idiopathic Celecoxib and night-splint. Travelled to England to his father and attended a London 
Hospital privately, monthly for three years. Good response. 
30 Whiplash RTA NSAIDs and physiotherapy Chronic pain developed. Patient began abusing alcohol 
Facet joint syndrome required and increased his illicit drug-use. Referred to group 
cervical nerve-block. Risotomy. therapy in Dublin for bereavement issues and
benefited from same. Referred to Pain Management 
Service.
35 Whiplash RTA NSAIDs and Celecoxib. Pain worsened. Patient became depressed and 
Paroxetine and Bromazepam referred to psychiatry.
prescribed. 
Table 1: Timescale of injuries
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for both suicide2 and depression.3 The involvement of psycho-
logical therapists in the treatment of chronic pain is now
considered essential5 as is the role of liaison psychiatry.6 Pain
clinics commonly combine anaesthetists, psychiatrists and
psychologists, a feature that is likely to grow with the exten-
sion of Consultation-Liaison psychiatry. 
Conclusion
Oxycodone is an opiate with anxiolytic and euphoriant
effects. It is widely prescribed in Ireland and the UK as a
treatment for chronic pain, its only approved indication.
It has a greater oral bio-availability than morphine and is
estimated to be approximately twice as potent.10
As the diagnosis of chronic pain syndrome increases in
frequency, and opiate prescription rates worldwide are main-
tained, this case highlights the potential of opiate abuse/
dependence and drug diversion emerging as a significant
medical problem in CPS patients in Europe, as in the US.
Our case report illustrates oxycodone’s abuse potential and
we must expect to see more of the same in the future, and be
suitably circumspect in our prescribing, particularly in those
with a history of illicit drug use, harmful use of alcohol or
prescription drug misuse.9
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